Valence Discovery Grows Leadership Team with Key Drug Discovery Hires

MONTREAL & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #AI--Valence Discovery (“Valence”), a leader in AI-driven drug discovery harnessing the power of computation and fit-for-purpose data generation to design differentiated small molecules, announced today the expansion of its leadership team with the additions of Guillaume Barbe, Ph.D. as Vice President, Head of Drug Discovery, Mike Nolan, Ph.D. as Vice President, Head of Biology, and Brian DeChristopher, Ph.D. as Senior Director, Head of Chemical Sciences